Riskpilot← Back to searchSign inGet full accessSENTRUM APOTEK AS
ASActiveOrg 984246900Rosenkrantzgate 9, 0159 OsloRetail sale of pharmaceutical products · NACE 4773Est. 20020 employees
Revenue 2020
NOK 0
EBITDA margin
—
-1347% vs 2019
Equity ratio
98.5%
Financial strength
Net profit 2020
NOK -45K
-106% vs 2019
| Revenue | NOK 0 | — |
| EBITDA | NOK -53K | -1347% |
| Net profit | NOK -45K | -106% |
| Total assets | NOK 2,6M | -19% |
| Equity | NOK 2,6M | -3% |
| Employees | 0 | — |
Legal name
SENTRUM APOTEK AS
Org number
984246900
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
23. februar 2002
Share capital
NOK 13 500 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Handel og produksjon av legemidler og helserelaterte produkter og alt som naturlig dertil henhører, samt delta i annen virksomhet av samme eller lignende art.
Address
Rosenkrantzgate 9, 0159 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 |
| Staff expenses | 3 | −0 | −0 | −9 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −104 | −83 | −12 | −38 | −22 | −8 | −14 | −13 | −12 | −4 | 0 | −4 | −53 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −104 | −83 | −12 | −38 | −22 | −8 | −14 | −13 | −12 | −4 | 0 | −4 | −53 |
| Net financials | −1 | −12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −105 | −95 | −12 | −38 | −22 | −8 | −14 | −13 | −12 | −4 | 0 | −4 | −53 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −709 | −8 |
| Net profit | −105 | −95 | −12 | −38 | −22 | −8 | −14 | −13 | −12 | −4 | 0 | 705 | −45 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 42 | 15 | 15 | 1 318 | 1 634 | 1 634 | 1 634 | 1 634 | 1 634 | 1 634 | 2 171 | 3 224 | 2 605 |
| Equity | −2 516 | −2 611 | −2 622 | −1 345 | −1 051 | −1 060 | −1 073 | −1 086 | −1 098 | −1 102 | −565 | 2 653 | 2 565 |
| Long-term debt | 2 248 | 0 | 0 | 0 | 0 | 2 637 | 2 637 | 2 637 | 2 637 | 2 637 | 2 637 | 0 | 0 |
| Short-term debt | 309 | 2 626 | 2 637 | 2 663 | 2 685 | 56 | 70 | 83 | 95 | 99 | 99 | 572 | 39 |
| Total debt | 2 558 | 2 626 | 2 637 | 2 663 | 2 685 | 2 694 | 2 707 | 2 720 | 2 732 | 2 736 | 2 736 | 572 | 39 |
EBITDA margin
-5344400.0%
This company
15.8%
Market median
-33825416% vs market
20082020
Equity ratio
98.5%
This company
38.2%
Market median
+158% vs market
20082020
Return on equity
-1.8%
This company
18.4%
Market median
-110% vs market
20082020
Net profit margin
-4510300.0%
This company
8.1%
Market median
-55682816% vs market
20082020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20082020
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20082020
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BG Contact Person | Contact Person | 2011 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2011 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SENTRUM APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørn Gilbo | Contact Person | 0 companies |
| Ole Petter Gilbo | Chairman | 0 companies |